Application for quotation of securities - RAD

Jul 27, 2026 at 8:53 PM EDT · Issued by Radiopharm Theranostics Limited via ASX

Filed with ASX · Jul 27, 2026 at 8:53 PM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-rad-3

Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 6 Announcement Summary Entity name RADIOPHARM THERANOSTICS LIMITED Announcement Type New announcement Date of this announcement Tuesday July 28, 2026 The +securities to be...

View Attachment

6ix hasn’t read this filing yet.

Radiopharm Theranostics Limited on 6ix

Earlier from Radiopharm Theranostics

Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up to Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase PlanJul 27
RAD completes A$12.5 M placement and launches A$6 M SPPJul 24
Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-ImmunotherapyJul 22
RAD Achieves Partial Response in Phase 1 Trial of RAD204Jul 21
Radiopharm Theranostics Reports Business UpdateApr 23

Later from Radiopharm Theranostics

Notice Under Section 708AJul 28
ProspectusJul 30
Target market determination (TMD)Jul 30
Change in substantial holdingJul 30
Quarterly Activities/Appendix 4C Cash Flow ReportJul 30

All Radiopharm Theranostics news releases

Follow Radiopharm Theranostics into a list and get an email when it puts out news.

Follow Radiopharm Theranostics